Monographie - Methylprednisolone acetate - Stabilis 4.0

Last update :
19/11/2024

Anti-inflammatory

Methylprednisolone acetate

injection

Stability in solutions

Stability of mixtures

Factors which affect stability

Compatibility

Route of administration

References

pdf

Chemical structure

Tradename

Tradename

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

A Metapred	United States of America
Adlone	United States of America
Cipridanol	Colombia
Cryosolona	Mexico
Dep Medalone	United States of America
Depo Medorin	Spain
Depo Medrol	Belgium, Brazil, Canada, Croatia, Denmark, Egypt, Finland, France, Greece, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Republic of South Africa, russian, Sweden, Switzerland, Turkey, United States of America
Depo Medrone	Great Britain
Depo Provera	Hungary
Depoject	United States of America
Depopred	United States of America
Duralone	United States of America
Lemod Depo	Serbia
Medrate	Germany
Methylone	United States of America
Solumet	Finland

References

injection

References : Methylprednisolone acetate

	Type	Publication
1085	Journal	Irving HD, Burbridge BE. Incompatibility of contrast agents with intravascular medications. Radiology 1989 ; 173: 91-92.
1620	Journal	Saverio Robustelli della Cuna F, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM. Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration. Am J Health-Syst Pharm 2001 ; 58: 1753-1756.
2109	Journal	Pelletier E, Forest JM, Hildgen P. Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels. Pharmactuel 2006 ; 39: 71-75.
2261	Journal	Fernandez C, Pelloquin A, Berthoume M, Bellanger A, Farinotti R. Stabilité et compatibilité de l'association ondansétron-méthylprednisolone en solution. Can J Hosp Pharm 2008 ; 61, 3: 191-195.
3408	Journal	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3545	Manufacturer	Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit Mylan SAS 2009
3604	Manufacturer	Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit Sanofi Aventis France 2012
4528	Journal	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61

Mentions Légales